Biosynex Capital Reinvestment Ratio
Biosynex capital reinvestment ratio. Biosynex (ALBIO) has a Capital Reinvestment Ratio of 2.19x as of December 2024, meaning it reinvests 2% of its operating cash flow (€1.26 Million) in capital expenditures (€2.77 Million). See ALBIO free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Biosynex (2009–2022)
Capital reinvestment ratio of Biosynex from 2009 to 2022. This chart tracks Biosynex's Capital Reinvestment Ratio across 7 annual periods. See ALBIO financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Biosynex Capital Reinvestment Ratio by Year (2009–2022)
Biosynex capital reinvestment ratio by year from 2009 to 2022. For the full cash flow conversion analysis, see how efficiently does Biosynex generate cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 6.08x | €4.95 Million | €30.08 Million | ▲ +3413.2% |
| 2021 | 0.17x | €109.83 Million | €19.02 Million | ▼ -39.9% |
| 2020 | 0.29x | €31.64 Million | €9.12 Million | ▼ -96.5% |
| 2019 | 8.26x | €1.10 Million | €9.12 Million | ▼ -57.7% |
| 2018 | 19.52x | €467.12K | €9.12 Million | ▲ +3.8% |
| 2017 | 18.81x | €484.82K | €9.12 Million | ▲ +2801.8% |
| 2009 | 0.65x | €72.40K | €46.92K | — |